Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines - Daiichi Sankyo Co (OTC:DSNKY)

Australia biotech startup Psylo has inked a sponsored research agreement with global Japanese pharmaceutical company Daiichi Sankyo (OTCMKTS: DSNKY) toward advancing antidepressant psychiatric medicines.

Related Keywords

Australia ,Philadelphia ,Pennsylvania ,United States ,Japan ,Japanese ,Matthew Burkhardt ,Daiichi Sankyo ,Josh Ismin ,Sam Banister , ,Building Australia ,Psychedelics Industry ,